A new DRUG TRIALS SNAPSHOT is now available.
IMFINZI is a drug for the treatment of a type of bladder and urinary tract cancer called urothelial carcinoma. IMFINZI may be used when:
- cancer has spread (locally advanced or metastatic urothelial carcinoma) and,
- chemotherapy that contains platinum did not work or is no longer working.
IMFINZI was approved under FDA’s accelerated approval program, which provides earlier patient access to a promising new drug while the company continues to conduct clinical trials to confirm that the drug works well.